M.S. Henkelman

461 total citations
8 papers, 396 citations indexed

About

M.S. Henkelman is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M.S. Henkelman has authored 8 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 2 papers in Molecular Biology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in M.S. Henkelman's work include Estrogen and related hormone effects (4 papers), Cancer therapeutics and mechanisms (1 paper) and Endometriosis Research and Treatment (1 paper). M.S. Henkelman is often cited by papers focused on Estrogen and related hormone effects (4 papers), Cancer therapeutics and mechanisms (1 paper) and Endometriosis Research and Treatment (1 paper). M.S. Henkelman collaborates with scholars based in Netherlands. M.S. Henkelman's co-authors include Buddy Setyono-Han, Jan G.M. Klijn, John A. Foekens, J.G.M. Klijn, Marinus A. Blankenstein, Henk Portengen, J. Alexieva-Figusch, J.A. Foekens, P. van der Schoot and Frank H. de Jong and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Clinica Chimica Acta and PubMed.

In The Last Decade

M.S. Henkelman

8 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.S. Henkelman Netherlands 6 186 132 129 115 106 8 396
Kuo-Pao Yang United States 10 105 0.6× 105 0.8× 144 1.1× 107 0.9× 29 0.3× 13 458
Laurent Bermont France 11 83 0.4× 207 1.6× 78 0.6× 78 0.7× 16 0.2× 23 398
Jacques-Pierre Moreau France 6 28 0.2× 121 0.9× 100 0.8× 118 1.0× 150 1.4× 6 337
Lucy Y.-H. Tseng United States 12 142 0.8× 320 2.4× 35 0.3× 471 4.1× 28 0.3× 15 618
Shan Wang‐Gohrke Germany 13 211 1.1× 274 2.1× 259 2.0× 28 0.2× 29 0.3× 18 565
Hiroko Misawa Japan 12 74 0.4× 235 1.8× 139 1.1× 154 1.3× 25 0.2× 17 450
Hideshi Hirayu Japan 11 92 0.5× 179 1.4× 41 0.3× 259 2.3× 16 0.2× 19 413
I.R. Willshire United Kingdom 5 56 0.3× 192 1.5× 83 0.6× 64 0.6× 12 0.1× 7 380
Donatella Amendola Italy 10 35 0.2× 147 1.1× 59 0.5× 68 0.6× 28 0.3× 13 335
Lidia Cerquetti Italy 13 50 0.3× 112 0.8× 42 0.3× 167 1.5× 32 0.3× 19 426

Countries citing papers authored by M.S. Henkelman

Since Specialization
Citations

This map shows the geographic impact of M.S. Henkelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.S. Henkelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.S. Henkelman more than expected).

Fields of papers citing papers by M.S. Henkelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.S. Henkelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.S. Henkelman. The network helps show where M.S. Henkelman may publish in the future.

Co-authorship network of co-authors of M.S. Henkelman

This figure shows the co-authorship network connecting the top 25 collaborators of M.S. Henkelman. A scholar is included among the top collaborators of M.S. Henkelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.S. Henkelman. M.S. Henkelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Setyono-Han, Buddy, M.S. Henkelman, John A. Foekens, & Jan G.M. Klijn. (1987). Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells.. PubMed. 47(6). 1566–70. 169 indexed citations
2.
Bakker, G.H., Buddy Setyono-Han, M.S. Henkelman, et al.. (1987). Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.. PubMed. 71(11). 1021–7. 41 indexed citations
3.
Foekens, J.A., et al.. (1986). Direct effects of LHRH analogs on tumor cells. European Journal of Cancer and Clinical Oncology. 22(6). 725–725. 2 indexed citations
4.
Foekens, J.A., et al.. (1986). Combined effects of Buserelin, estradiol and Tamoxifen on the growth of MCF-7 human breast cancer cells in vitro. Biochemical and Biophysical Research Communications. 140(2). 550–556. 28 indexed citations
5.
Blankenstein, Marinus A., M.S. Henkelman, & J.G.M. Klijn. (1985). Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells. European Journal of Cancer and Clinical Oncology. 21(12). 1493–1499. 53 indexed citations
6.
Blankenstein, Marinus A., M.S. Henkelman, & J.G.M. Klijn. (1983). 286 An analogue of LHRH antagonizes the growth-stimulating effect of oestradiol on human breast cancer cells in culture (MCF-7). Journal of Steroid Biochemistry. 19. 95–95. 4 indexed citations
7.
Henkelman, M.S., et al.. (1980). Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.. PubMed. 40(7). 2557–61. 94 indexed citations
8.
Portengen, Henk, et al.. (1975). Quantitation of estrogen receptors in human breast cancer by agar gel electrophoresis. Clinica Chimica Acta. 64(1). 27–38. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026